| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (KPB-01 + methicillin-susceptible) |
- |
- |
4 － ? |
Linezolid (PNU-100766, U-100766, Zyvox)  |
269 |
| Staphylococcus aureus (KPB-04 + methicillin-susceptible) |
- |
- |
0.25 － ? |
Nafcillin (Unipen, Nafcil) |
269 |
| Staphylococcus aureus (KPB-04 + methicillin-susceptible) |
- |
- |
0.5 － ? |
Telavancin (TD-6424, Vibativ) |
209 |
| Staphylococcus aureus (KPB-04 + methicillin-susceptible) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
269 |
| Staphylococcus aureus (KPB-04 + methicillin-susceptible) |
- |
- |
2 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
269 |
| Staphylococcus aureus (KSA) |
- |
- |
0.125 － ? |
Levofloxacin (Levaquin, Quixin) |
670 |
| Staphylococcus aureus (KSA) |
- |
- |
0.5 － ? |
Imipenem |
670 |
| Staphylococcus aureus (KSA) |
- |
- |
0.5 － ? |
Teicoplanin (Targocid) |
670 |
| Staphylococcus aureus (KSA) |
- |
- |
0.5 － ? |
Vancomycin (Vancocyn, Lyphocin) |
670 |
| Staphylococcus aureus (KSA) |
- |
- |
4 － ? |
Ceftizoxime (Cefizox) |
670 |
| Staphylococcus aureus (KSA) |
- |
- |
8 － ? |
Fosfomycin (Phosphonomycin, Phosphomycin, Monurol) |
670 |
| Staphylococcus aureus (KSA) |
- |
- |
8 － ? |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
670 |
| Staphylococcus aureus (KSA) |
- |
- |
16 － ? |
Bacitracin (Baci-IM) |
670 |
| Staphylococcus aureus (KSA) |
- |
- |
32 － ? |
D-cycloserine |
670 |
| Staphylococcus aureus (KSA) |
- |
- |
64 － ? |
Cefalexin (Keflex) |
670 |
| Staphylococcus aureus (KT 0116 + methicillin-resistant) |
- |
- |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
397 |
| Staphylococcus aureus (KT 0116 + methicillin-resistant) |
- |
- |
16 － ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
397 |
| Staphylococcus aureus (KT 0116 + methicillin-resistant) |
- |
- |
16 － ? |
Minocycline (Minocycline hydrochloride, Minocin) |
397 |
| Staphylococcus aureus (KT 0116 + methicillin-resistant) |
- |
- |
>128 － ? |
Ceftriaxone (Rocephin) |
397 |
| Staphylococcus aureus (KT 0116 + methicillin-resistant) |
- |
- |
>128 － ? |
Levofloxacin (Levaquin, Quixin) |
397 |
| Staphylococcus aureus (KTCC 1916) |
- |
- |
750 － ? |
Gamma linolenic acid |
867 |
| Staphylococcus aureus (KTCC 1916) |
- |
- |
1500 － ? |
Linoleic acid |
867 |
| Staphylococcus aureus (KTCC 1916) |
- |
- |
1750 － ? |
Alpha-Linolenic acid |
867 |
| Staphylococcus aureus (KTCC 1916) |
- |
- |
<4000 － ? |
Pinolenic acid |
867 |
| Staphylococcus aureus (KTCC 1916) |
- |
- |
<4000 － ? |
Trilinolein (Linolein) |
867 |
| Staphylococcus aureus (KTCC 1916) |
- |
- |
<4000 － ? |
Triolein |
867 |
| Staphylococcus aureus (KVR) |
- |
- |
0.0625 － ? |
Teicoplanin (Targocid) |
670 |
| Staphylococcus aureus (KVR) |
- |
- |
0.125 － ? |
Imipenem |
670 |